FDA Inspection 1310170 — Kamps Rx Genetics
The FDA completed an inspection of Kamps Rx Genetics on March 31, 2026 in Darlington, WI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 31, 2026
- Fiscal Year
- 2026
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Darlington, WI (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 4093 | 21 CFR 530.11(d) | ELDU - producer causes Illegal drug residue |
| 4298 | 21 CFR 530.11(a) | Prescribed directions - not followed |